News

Biosenta Inc. announces that it has entered into an agreement to settle $1,015,088.47 of debt through issuance of 3,625,315 common shares.

Biosenta has granted an aggregate of 1,017,000 stock options.

Biosenta announces that it has granted to certain directors, officers, employees and consultants of the Company 350,000 stock options.

Biosenta will enter into a series of prime plus 5% unsecured promissory notes in consideration for cash investments in the amount of $85,000

Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360.